Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Anticancer Research|May 23, 2002
Expression of C-KIT and HER-2 tyrosine kinase receptors in poor-prognosis breast cancerS Palmu, K O Söderström, K Quazi, et al.
European Journal of Clinical Pharmacology|April 17, 1999
A double-blind study of MPV-2213ad, a novel aromatase inhibitor, in healthy male subjectsO Ahokoski, K Irjala, S Huhtala, et al.
Anticancer Research|August 6, 2000
Docetaxel and autonomic cardiovascular control in anthracycline treated breast cancer patientsE Ekholm, V Rantanen, M Bergman, et al.
Anticancer Research|August 11, 2001
Modulation of IgG and complement receptor expression of phagocytes in kidney cancer patients during treatment with interferon-alphaE Salminen, M Kankuri, J Nuutila, et al.
Bioresource Technology|March 27, 2001
Anaerobically digested poultry slaughterhouse wastes as fertiliser in agricultureE Salminen, J Rintala, J Härkönen, et al.
British Journal of Clinical Pharmacology|March 10, 1998
Hormonal effects of MPV-2213ad, a new selective aromatase inhibitor, in healthy male subjects. A phase I studyO Ahokoski, K Irjala, R Huupponen, et al.
British Journal of Cancer|October 12, 2000
Cell cycle regulators p27 and pRb in lymphomas - correlation with histology and proliferative activityM Kiviniemi, I Sauroja, A Rajamäki, et al.
Cancer|September 11, 2001
Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma: a phase II studyM Kankuri, T T Pelliniemi, S Pyrhönen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2012
Physicians' self-assessment of cancer pain treatment skills--more training requiredM Silvoniemi, T Vasankari, T Vahlberg, et al.
Anti-Cancer Drugs|January 25, 2003
Docetaxel with epirubicin--investigations on cardiac safetyE Salminen, K Syvänen, J Korpela, et al.
Pageof 16